Teva Pharmaceutical Industries TEVA
NYSE TEVA
$39.53 +0.20 (+0.51%)
At close: Oct 2, 2026 · 4:00 PM EDT

Teva Pharmaceutical Industries (TEVA) Return on Sales [ROS] (2009 - 2026)

Updated

Teva Pharmaceutical Industries (TEVA) recorded Return on Sales [ROS] of -5.58% in Q2 2026, down 16.47 percentage points from 10.90% a year earlier and down 21.95 percentage points from the prior quarter.

Analysis

Teva Pharmaceutical Industries (TEVA) Return on Sales [ROS] (2009 - 2026) Analysis & Trends

On a TTM basis, Teva Pharmaceutical Industries' Return on Sales [ROS] came in at 9.26% as of Jun 30, 2026, up 3.88 percentage points year-over-year; for FY2025, it was 12.50%, up 14.33 percentage points from FY2024.

  • Annual Return on Sales [ROS] has a five-year change of +33.94 percentage points (FY2020 to FY2025).
  • Across earlier years, Return on Sales [ROS] came in at -1.83% in FY2024 (-4.56 pp), 2.73% in FY2023 (+17.45 pp), -14.72% in FY2022 (-25.53 pp) and 10.81% in FY2021 (+32.25 pp).
  • The Q2 2026 figure is the lowest quarterly Return on Sales [ROS] since Q1 2024.
  • On a year-over-year basis, Return on Sales [ROS] rose in five of the last eight quarters, with an average year-over-year change of +2.10 percentage points.
  • Peak year-over-year performance for Return on Sales [ROS] in the last five years was a gain of 125.18 percentage points in Q3 2021, against a drop of 40.43 percentage points in Q2 2022 at the low end.
  • Per Business Quant, the preceding three quarters came in at 16.37% (Q1 2026), 6.37% (Q4 2025) and 19.69% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 28.21%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 37.86%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -3.52%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 32.97%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 20.57%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 34.95%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -133.21%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 28.37%
10 Teva Pharmaceutical Industries 46.06 Bn 32.91 Bn 2.15 Bn -5.58%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -5.58%
Mar 31, 2026 16.37%
Dec 31, 2025 6.37%
Sep 30, 2025 19.69%
Jun 30, 2025 10.90%
Mar 31, 2025 13.34%
Dec 31, 2024 -0.69%
Sep 30, 2024 -1.18%
Jun 30, 2024 -0.12%
Mar 31, 2024 -5.71%
Dec 31, 2023 16.96%
Sep 30, 2023 8.94%
Jun 30, 2023 -16.86%
Mar 31, 2023 -0.36%
Dec 31, 2022 -24.20%
Sep 30, 2022 11.79%
Jun 30, 2022 -25.54%
Mar 31, 2022 -19.48%
Dec 31, 2021 1.90%
Sep 30, 2021 16.03%
API Access

Teva Pharmaceutical Industries Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=TEVA&period=max&api_key=YOUR_API_KEY